Last updated on November 2018

An Efficacy Study of Pomalidomide in Patient With Multiple Myeloma in Routine Clinical Practice


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Multiple Myeloma
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Adult patient (age 18 yrs),
  • Diagnosed with multiple myeloma (measurable or not),
  • In whom pomalidomide treatment was first initiated between October 1, 2014, and September 30, 2017,
  • Patient already included in the Imnovid registry,
  • Having received oral and written information about the study, and having given their consent to participate.

Exclusion Criteria:

  • Previous participation in a clinical trial with pomalidomide,
  • Treatment with pomalidomide in a previous line,
  • Simultaneous participation in a clinical trial.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.